1	The	The	B-NP	DT	O	3	NMOD	-1
2	differential	differential	I-NP	JJ	O	3	NMOD	-1
3	regulation	regulation	I-NP	NN	O	14	SUB	16	regulation
4	of	of	B-PP	IN	O	3	NMOD	-1
5	human	human	B-NP	JJ	B-protein	8	NMOD	-1
6	telomerase	telomerase	I-NP	NN	I-protein	8	NMOD	-1
7	reverse	reverse	I-NP	JJ	I-protein	8	NMOD	-1
8	transcriptase	transcriptase	I-NP	NN	I-protein	13	NMOD	-1
9	and	and	O	CC	O	13	NMOD	-1
10	vascular	vascular	B-NP	JJ	B-protein	13	NMOD	-1
11	endothelial	endothelial	I-NP	JJ	I-protein	13	NMOD	-1
12	growth	growth	I-NP	NN	I-protein	13	NMOD	0
13	factor	factor	I-NP	NN	I-protein	4	PMOD	-1
14	may	may	B-VP	MD	O	0	ROOT	-1
15	contribute	contribute	I-VP	VB	O	14	VC	0
16	to	to	B-PP	TO	O	15	VMOD	-1
17	the	the	B-NP	DT	O	21	NMOD	-1
18	clinically	clinically	I-NP	RB	O	20	AMOD	-1
19	more	more	I-NP	RBR	O	20	AMOD	-1
20	aggressive	aggressive	I-NP	JJ	O	21	NMOD	-1
21	behavior	behavior	I-NP	NN	O	16	PMOD	-1
22	of	of	B-PP	IN	O	21	NMOD	-1
23	p63-positive	p63-positive	B-NP	JJ	O	25	NMOD	-1
24	breast	breast	I-NP	NN	O	25	NMOD	-1
25	carcinomas	carcinoma	I-NP	NNS	O	22	PMOD	-1
26	.	.	O	.	O	14	P	-1

1	p63	p63	B-NP	NN	B-protein	5	NMOD	-1
2	,	,	O	,	O	5	P	-1
3	a	a	B-NP	DT	O	5	NMOD	-1
4	p53	p53	I-NP	NN	B-protein	5	NMOD	-1
5	homologue	homologue	I-NP	NN	I-protein	7	SUB	-1
6	,	,	O	,	O	5	P	-1
7	is	be	B-VP	VBZ	O	0	ROOT	-1
8	a	a	B-NP	DT	O	11	NMOD	-1
9	myoepithelial	myoepithelial	I-NP	JJ	B-protein	11	NMOD	-1
10	cell	cell	I-NP	NN	I-protein	11	NMOD	-1
11	marker	marker	I-NP	NN	I-protein	7	PRD	-1
12	in	in	B-PP	IN	O	11	NMOD	-1
13	the	the	B-NP	DT	O	16	NMOD	-1
14	normal	normal	I-NP	JJ	O	16	NMOD	-1
15	mammary	mammary	I-NP	JJ	O	16	NMOD	-1
16	gland	gland	I-NP	NN	O	20	NMOD	-1
17	but	but	O	CC	O	20	NMOD	-1
18	p63-positive	p63-positive	B-NP	JJ	B-cell_type	20	NMOD	-1
19	neoplastic	neoplastic	I-NP	JJ	I-cell_type	20	NMOD	-1
20	cells	cell	I-NP	NNS	I-cell_type	12	PMOD	-1
21	may	may	B-VP	MD	O	7	VMOD	-1
22	be	be	I-VP	VB	O	21	VC	-1
23	found	find	I-VP	VBN	O	22	VC	0
24	in	in	B-PP	IN	O	23	VMOD	-1
25	up	up	B-NP	IN	O	28	NMOD	-1
26	to	to	I-NP	TO	O	25	AMOD	-1
27	11	11	I-NP	CD	O	25	AMOD	-1
28	%	%	I-NP	NN	O	24	PMOD	-1
29	of	of	B-PP	IN	O	28	NMOD	-1
30	invasive	invasive	B-NP	JJ	O	32	NMOD	-1
31	breast	breast	I-NP	NN	O	32	NMOD	-1
32	carcinomas	carcinoma	I-NP	NNS	O	29	PMOD	-1
33	.	.	O	.	O	7	P	-1

1	This	This	B-NP	DT	O	2	NMOD	-1
2	study	study	I-NP	NN	O	3	SUB	-1
3	aims	aim	B-VP	VBZ	O	0	ROOT	-1
4	to	to	I-VP	TO	O	5	VMOD	-1
5	verify	verify	I-VP	VB	O	3	VMOD	-1
6	the	the	B-NP	DT	O	7	NMOD	-1
7	relationship	relationship	I-NP	NN	O	5	OBJ	-1
8	between	between	B-PP	IN	O	7	NMOD	-1
9	p63	p63	B-NP	NN	B-protein	10	NMOD	-1
10	expression	expression	I-NP	NN	O	14	NMOD	9	expression
11	and	and	O	CC	O	14	NMOD	-1
12	several	several	B-NP	JJ	O	14	NMOD	-1
13	clinicopathological	clinicopathological	I-NP	JJ	O	14	NMOD	-1
14	features	feature	I-NP	NNS	O	17	NMOD	-1
15	and	and	O	CC	O	17	NMOD	-1
16	tumor	tumor	B-NP	NN	O	17	NMOD	-1
17	markers	marker	I-NP	NNS	O	8	PMOD	-1
18	of	of	B-PP	IN	O	17	NMOD	-1
19	clinical	clinical	B-NP	JJ	O	20	NMOD	-1
20	significance	significance	I-NP	NN	O	18	PMOD	-1
21	in	in	B-PP	IN	O	20	NMOD	-1
22	breast	breast	B-NP	NN	O	23	NMOD	-1
23	pathology	pathology	I-NP	NN	O	21	PMOD	-1
24	including	include	B-PP	VBG	O	23	NMOD	-1
25	key	key	B-NP	JJ	O	26	NMOD	-1
26	regulators	regulator	I-NP	NNS	O	40	NMOD	-1
27	of	of	B-PP	IN	O	26	NMOD	-1
28	the	the	B-NP	DT	O	30	NMOD	-1
29	cell	cell	I-NP	NN	O	30	NMOD	-1
30	cycle	cycle	I-NP	NN	O	27	PMOD	0
31	,	,	O	,	O	40	P	-1
32	oncogenes	oncogene	B-NP	NNS	B-DNA	40	NMOD	-1
33	,	,	O	,	O	40	P	-1
34	apoptosis-related	apoptosis-related	B-NP	JJ	B-protein	35	NMOD	-1
35	proteins	protein	I-NP	NNS	I-protein	40	NMOD	-1
36	,	,	O	,	O	40	P	-1
37	metalloproteinases	metalloproteinas	B-NP	NNS	B-protein	40	NMOD	-1
38	and	and	O	CC	O	40	NMOD	-1
39	their	their	B-NP	PRP$	O	40	NMOD	-1
40	inhibitors	inhibitor	I-NP	NNS	O	24	PMOD	-1
41	.	.	O	.	O	3	P	-1

1	Immunohistochemistry	Immunohistochemistry	B-NP	NN	O	6	SUB	-1
2	with	with	B-PP	IN	O	1	NMOD	-1
3	27	27	B-NP	CD	O	5	NMOD	-1
4	primary	primary	I-NP	JJ	O	5	NMOD	-1
5	antibodies	antibody	I-NP	NNS	O	2	PMOD	-1
6	was	be	B-VP	VBD	O	0	ROOT	-1
7	performed	perform	I-VP	VBN	O	6	VC	-1
8	in	in	B-PP	IN	O	7	VMOD	-1
9	100	100	B-NP	CD	O	12	NMOD	-1
10	formalin-fixed	formalin-fixed	I-NP	JJ	O	12	NMOD	-1
11	paraffin-embedded	paraffin-embedded	I-NP	JJ	O	12	NMOD	-1
12	samples	sample	I-NP	NNS	O	8	PMOD	-1
13	of	of	B-PP	IN	O	12	NMOD	-1
14	invasive	invasive	B-NP	JJ	O	16	NMOD	-1
15	ductal	ductal	I-NP	JJ	O	16	NMOD	-1
16	carcinomas	carcinoma	I-NP	NNS	O	13	PMOD	-1
17	.	.	O	.	O	6	P	-1

1	p63-positive	p63-positive	B-NP	JJ	B-cell_type	2	NMOD	-1
2	cells	cell	I-NP	NNS	I-cell_type	3	SUB	-1
3	were	be	B-VP	VBD	O	0	ROOT	-1
4	found	find	I-VP	VBN	O	3	VC	14	found
5	in	in	B-PP	IN	O	4	VMOD	-1
6	16	16	B-NP	CD	O	7	NMOD	-1
7	%	%	I-NP	NN	O	5	PMOD	-1
8	of	of	B-PP	IN	O	7	NMOD	-1
9	carcinomas	carcinoma	B-NP	NNS	O	8	PMOD	-1
10	.	.	O	.	O	3	P	-1

1	p63-positive	p63-positive	B-NP	JJ	O	2	NMOD	-1
2	carcinomas	carcinoma	I-NP	NNS	O	3	SUB	-1
3	were	be	B-VP	VBD	O	9	VMOD	-1
4	poorly	poorly	I-VP	RB	O	3	VMOD	-1
5	differentiated	differentiate	I-VP	VBN	O	3	VC	2	differentiated
6	,	,	O	,	O	9	P	-1
7	hormone	hormone	B-NP	NN	O	9	NMOD	-1
8	receptor-negative	receptor-negative	I-NP	JJ	O	9	NMOD	-1
9	neoplasms	neoplasm	I-NP	NNS	O	0	ROOT	-1
10	with	with	B-PP	IN	O	9	NMOD	-1
11	a	a	B-NP	DT	O	14	NMOD	-1
12	high	high	I-NP	JJ	O	14	NMOD	-1
13	proliferation	proliferation	I-NP	NN	O	14	NMOD	4	proliferation
14	rate	rate	I-NP	NN	O	10	PMOD	-1
15	.	.	O	.	O	9	P	-1

1	p63	p63	B-NP	NN	B-protein	3	SUB	-1
2	also	also	B-ADVP	RB	O	3	VMOD	-1
3	correlated	correlate	B-VP	VBD	O	0	ROOT	-1
4	with	with	B-PP	IN	O	3	VMOD	-1
5	advanced	advance	B-NP	VBN	O	7	NMOD	-1
6	pathological	pathological	I-NP	JJ	O	7	NMOD	-1
7	stage	stage	I-NP	NN	O	4	PMOD	-1
8	,	,	O	,	O	14	P	-1
9	tumor	tumor	B-NP	NN	O	10	NMOD	-1
10	size	size	I-NP	NN	O	14	NMOD	-1
11	,	,	O	,	O	14	P	-1
12	and	and	O	CC	O	14	NMOD	-1
13	the	the	B-NP	DT	O	14	NMOD	-1
14	expression	expression	I-NP	NN	O	3	VMOD	9	expression
15	of	of	B-PP	IN	O	14	NMOD	-1
16	human	human	B-NP	JJ	B-protein	19	NMOD	-1
17	telomerase	telomerase	I-NP	NN	I-protein	19	NMOD	-1
18	reverse	reverse	I-NP	JJ	I-protein	19	NMOD	-1
19	transcriptase	transcriptase	I-NP	NN	I-protein	25	NMOD	-1
20	(	(	O	(	O	22	DEP	-1
21	hTERT	hTERT	B-NP	NN	O	22	DEP	-1
22	)	)	O	)	O	19	NMOD	-1
23	,	,	O	,	O	25	P	-1
24	tissue	tissue	B-NP	NN	O	25	NMOD	-1
25	inhibitor	inhibitor	I-NP	NN	O	15	PMOD	0
26	of	of	B-PP	IN	O	25	NMOD	-1
27	matrix	matrix	B-NP	NN	B-protein	28	NMOD	-1
28	metalloproteinase	metalloproteinase	I-NP	NN	I-protein	37	NMOD	-1
29	1	1	I-NP	CD	I-protein	28	NMOD	-1
30	(	(	O	(	O	32	DEP	-1
31	TIMP1	TIMP1	B-NP	NN	B-protein	32	DEP	-1
32	)	)	O	)	O	28	NMOD	-1
33	and	and	O	CC	O	37	NMOD	-1
34	vascular	vascular	B-NP	JJ	B-protein	37	NMOD	-1
35	endothelial	endothelial	I-NP	JJ	I-protein	37	NMOD	-1
36	growth	growth	I-NP	NN	I-protein	37	NMOD	0
37	factor	factor	I-NP	NN	I-protein	26	PMOD	-1
38	(	(	O	(	O	40	DEP	-1
39	VEGF	VEGF	B-NP	NN	B-protein	40	DEP	-1
40	)	)	O	)	O	37	NMOD	-1
41	.	.	O	.	O	3	P	-1

1	The	The	B-NP	DT	O	2	NMOD	-1
2	expression	expression	I-NP	NN	O	5	SUB	9	expression
3	of	of	B-PP	IN	O	2	NMOD	-1
4	TIMP1	TIMP1	B-NP	NN	B-protein	3	PMOD	-1
5	suggests	suggest	B-VP	VBZ	O	0	ROOT	-1
6	that	that	B-SBAR	IN	O	5	VMOD	-1
7	the	the	B-NP	DT	O	9	NMOD	-1
8	anti-proteolytic	anti-proteolytic	I-NP	JJ	O	9	NMOD	-1
9	stimuli	stimulus	I-NP	NNS	O	10	SUB	-1
10	may	may	B-VP	MD	O	6	SBAR	-1
11	be	be	I-VP	VB	O	10	VC	-1
12	preponderant	preponderant	B-ADJP	JJ	O	11	PRD	-1
13	in	in	B-PP	IN	O	12	AMOD	-1
14	p63-positive	p63-positive	B-NP	JJ	O	15	NMOD	-1
15	carcinomas	carcinoma	I-NP	NNS	O	13	PMOD	-1
16	.	.	O	.	O	5	P	-1

1	hTERT	hTERT	B-NP	NN	O	2	NMOD	-1
2	activity	activity	I-NP	NN	O	3	SUB	0
3	is	be	B-VP	VBZ	O	0	ROOT	-1
4	associated	associate	I-VP	VBN	O	3	VC	0
5	with	with	B-PP	IN	O	4	VMOD	-1
6	nodal	nodal	B-NP	JJ	B-protein	7	NMOD	-1
7	metastases	metastasis	I-NP	NNS	I-protein	10	NMOD	0
8	and	and	O	CC	O	10	NMOD	-1
9	cellular	cellular	B-NP	JJ	O	10	NMOD	-1
10	proliferation	proliferation	I-NP	NN	O	5	PMOD	0
11	.	.	O	.	O	3	P	-1

1	VEGF	VEGF	B-NP	NN	B-protein	2	SUB	-1
2	regulates	regulate	B-VP	VBZ	O	0	ROOT	16	regulates
3	angiogenesis	angiogenesis	B-NP	NN	O	2	OBJ	3	angiogenesis
4	,	,	O	,	O	3	P	-1
5	which	which	B-NP	WDT	O	3	NMOD	-1
6	is	be	B-VP	VBZ	O	5	SBAR	-1
7	also	also	B-ADVP	RB	O	6	VMOD	-1
8	a	a	B-NP	DT	O	10	NMOD	-1
9	fundamental	fundamental	I-NP	JJ	O	10	NMOD	-1
10	event	event	I-NP	NN	O	6	PRD	-1
11	in	in	B-PP	IN	O	6	VMOD	-1
12	the	the	B-NP	DT	O	13	NMOD	-1
13	process	process	I-NP	NN	O	11	PMOD	-1
14	of	of	B-PP	IN	O	13	NMOD	-1
15	tumor	tumor	B-NP	NN	O	16	NMOD	-1
16	growth	growth	I-NP	NN	O	19	NMOD	4	growth
17	and	and	O	CC	O	19	NMOD	-1
18	metastatic	metastatic	B-NP	JJ	O	19	NMOD	0
19	dissemination	dissemination	I-NP	NN	O	14	PMOD	-1
20	.	.	O	.	O	2	P	-1

1	Thus	Thus	B-ADVP	RB	O	14	VMOD	-1
2	,	,	O	,	O	14	P	-1
3	the	the	B-NP	DT	O	5	NMOD	-1
4	differential	differential	I-NP	JJ	O	5	NMOD	-1
5	regulation	regulation	I-NP	NN	O	14	SUB	16	regulation
6	of	of	B-PP	IN	O	5	NMOD	-1
7	hTERT	hTERT	B-NP	NN	O	9	NMOD	-1
8	and	and	I-NP	CC	O	9	NMOD	-1
9	VEGF	VEGF	I-NP	NN	B-protein	6	PMOD	-1
10	in	in	B-PP	IN	O	5	NMOD	-1
11	p63-positive	p63-positive	B-NP	JJ	O	13	NMOD	-1
12	breast	breast	I-NP	NN	O	13	NMOD	-1
13	carcinomas	carcinoma	I-NP	NNS	O	10	PMOD	-1
14	may	may	B-VP	MD	O	0	ROOT	-1
15	contribute	contribute	I-VP	VB	O	14	VC	0
16	to	to	B-PP	TO	O	15	VMOD	-1
17	the	the	B-NP	DT	O	21	NMOD	-1
18	clinically	clinically	I-NP	RB	O	20	AMOD	-1
19	more	more	I-NP	RBR	O	20	AMOD	-1
20	aggressive	aggressive	I-NP	JJ	O	21	NMOD	-1
21	behavior	behavior	I-NP	NN	O	16	PMOD	-1
22	of	of	B-PP	IN	O	21	NMOD	-1
23	these	these	B-NP	DT	O	24	NMOD	-1
24	neoplasms	neoplasm	I-NP	NNS	O	22	PMOD	-1
25	.	.	O	.	O	14	P	-1

